ReviewArchives of microbiology2025
A review of herbal therapeutics for the prevention and management of poxvirus infections.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Monkey pox (Mpox): pathogenesis, genetic shifts, vaccination strategies and clinical insights.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poxvirus continues to pose public health concerns due to sporadic outbreaks, zoonotic transmission, and limited treatment options. The accessibility of vaccines and antivirals does not resolve the problems of drug resistance, adverse effects, and limited accessibility, which underscores the necessity to find different therapeutic approaches. This review aims to explore the potential of herbal therapy as an effective and accessible treatment for human poxvirus infections. A comprehensive analysis of 10 selected medicinal plants with reported antiviral activity against poxviruses. Data from in-vitro, in-vivo, in-silico, and clinical studies were analyzed to assess mechanisms of action, active compounds, and immunomodulatory effects. Plants such as Azadirachta indica (neem), Curcuma longa (turmeric), and Echinacea purpurea exhibit antiviral activity by inhibiting viral replication, modulating immune responses, and suppressing inflammation. Several herbs stopped viruses directly, and others supported the body's natural defenses. Most evidence is preclinical, though some clinical data exist, particularly for Echinacea. Herbal remedies may provide new options for treating poxviruses and could help improve the effectiveness of available antiviral medication. However, more preclinical and clinical verification is necessary to show that the product is effective, safe, and appropriate for use. Integrating scientifically validated herbal therapies may provide cost-effective, accessible, and safer options for managing poxvirus infections, especially in low-resource settings.
Indexed as
Identifiers
40560228What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.